CGT SWOT analysis offers clues on where the industry is heading
Credit: Jason D. Williams, CCO, Wikimedia Commons If you’re reading this, you’re probably aware of the massive strides the cell and gene therapy (CGT) industry has made in the last few years. Between 2017 and 2022, six CGT products were approved by the U.S. Food and Drug Administration, but we saw eight approvals in 2023...